| 34.41 1.55 (4.72%) | 07-24 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 40.53 |
1-year : | 47.34 |
| Resists | First : | 34.7 |
Second : | 40.53 |
| Pivot price | 33.05 |
|||
| Supports | First : | 31.97 |
Second : | 30.29 |
| MAs | MA(5) : | 33.36 |
MA(20) : | 32.66 |
| MA(100) : | 33.4 |
MA(250) : | 38.34  |
|
| MACD | MACD : | 0.2 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 66.7 |
D(3) : | 62.6 |
| RSI | RSI(14): 59.8 |
|||
| 52-week | High : | 51.08 | Low : | 27.04 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ RELX ] has closed below upper band by 3.7%. Bollinger Bands are 27.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 34.75 - 34.88 | 34.88 - 35.01 |
| Low: | 33.13 - 33.29 | 33.29 - 33.45 |
| Close: | 34.15 - 34.4 | 34.4 - 34.64 |
RELX Plc is a global enterprise that delivers data-driven analytical solutions and strategic decision-making instruments to professional and corporate clients across North America, Europe, and other international markets. Its operations are structured into four distinct divisions: Risk, Scientific, Technical & Medical (STM), Legal, and Exhibitions. The Risk division specializes in providing advanced analytical platforms and decision support systems. These tools leverage a blend of publicly available and industry-specific data, integrated with sophisticated technology and algorithms, to help clients assess and forecast potential risks. Through its Scientific, Technical & Medical unit, RELX furnishes crucial information and analytical insights designed to foster scientific advancement and improve healthcare outcomes for institutions and practitioners alike. The Legal sector provides comprehensive legal, regulatory, and commercial intelligence, alongside analytical capabilities, enabling clients to make informed choices and enhance their operational efficiency. Finally, the Exhibitions division manages a portfolio of events, merging in-person interactions with data-driven and digital resources. This approach assists attendees in exploring market trends, identifying products, and facilitating business transactions. Established in 1903, the company, originally named Reed Elsevier PLC, adopted its current identity, RELX PLC, in July 2015. Its global headquarters are situated in London, United Kingdom.
Sun, 26 Jul 2026
Arrowstreet Capital Limited Partnership Acquires 2,763,766 Shares of Relx Plc $RELX - MarketBeat
Sun, 26 Jul 2026
RELX PLC (LON:REL) Just Reported Interim Earnings: Have Analysts Changed Their Mind On The Stock? - simplywall.st
Sat, 25 Jul 2026
Relx PLC R (RDEB.HM) H2 FY2025 earnings call transcript - Yahoo Finance
Fri, 24 Jul 2026
RELX PLC (RELX) Shares Surge 4.7% -- What GF Score of 79 Tells I - GuruFocus
Fri, 24 Jul 2026
Allspring Global Investments Holdings LLC Acquires 139,663 Shares of Relx Plc $RELX - MarketBeat
Thu, 23 Jul 2026
RELX PLC (REL.L) stock price, news, quote and history - Yahoo Finance Singapore
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Industrials
|
|
|
Industry:
Specialty Business Services
|
|
| Shares Out | 1,750 (M) |
| Shares Float | 7,220 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 4.9 (%) |
| Shares Short | 3,390 (K) |
| Shares Short P.Month | 3,600 (K) |
| EPS | 1.48 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.43 |
| Profit Margin | 21.5 % |
| Operating Margin | 31.4 % |
| Return on Assets (ttm) | 12.4 % |
| Return on Equity (ttm) | 70.5 % |
| Qtrly Rev. Growth | 1.2 % |
| Gross Profit (p.s.) | 3.63 |
| Sales Per Share | 5.48 |
| EBITDA (p.s.) | 1.82 |
| Qtrly Earnings Growth | 17 % |
| Operating Cash Flow | 2,840 (M) |
| Levered Free Cash Flow | 2,160 (M) |
| PE Ratio | 23.25 |
| PEG Ratio | 1.3 |
| Price to Book value | 80.02 |
| Price to Sales | 6.27 |
| Price to Cash Flow | 21.2 |
| Dividend | 0.66 |
| Forward Dividend | 0 |
| Dividend Yield | 1.9% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|